Saphenous vein graft interventions

Emmanouil S. Brilakis; Michael Lee; Julinda Mehilli; Konstantinos Marmagkiolis; Josep Rodes-Cabau; Rajesh Sachdeva; Anna Kotsia; George Christopoulos; Bavana V. Rangan; Atif Mohammed; Subhash Banerjee

doi:10.1007/s11936-014-0301-x

Saphenous vein graft interventions

Emmanouil S. Brilakis, Michael Lee, Julinda Mehilli, Konstantinos Marmagkiolis, Josep Rodes-Cabau, Rajesh Sachdeva, Anna Kotsia, George Christopoulos, Bavana V. Rangan, Atif Mohammed, Subhash Banerjee

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.

Original language	English (US)
Article number	301
Journal	Current Treatment Options in Cardiovascular Medicine
Volume	16
Issue number	5
DOIs	https://doi.org/10.1007/s11936-014-0301-x
State	Published - May 2014

Keywords

Drug eluting stent
Internal mammary artery
Outcomes
Percutaneous coronary intervention
Saphenous vein grafts

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11936-014-0301-x

Cite this

@article{8965cbe492a846f0866442ec7c5ae642,

title = "Saphenous vein graft interventions",

abstract = "Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.",

keywords = "Drug eluting stent, Internal mammary artery, Outcomes, Percutaneous coronary intervention, Saphenous vein grafts",

author = "Brilakis, {Emmanouil S.} and Michael Lee and Julinda Mehilli and Konstantinos Marmagkiolis and Josep Rodes-Cabau and Rajesh Sachdeva and Anna Kotsia and George Christopoulos and Rangan, {Bavana V.} and Atif Mohammed and Subhash Banerjee",

year = "2014",

month = may,

doi = "10.1007/s11936-014-0301-x",

language = "English (US)",

volume = "16",

journal = "Current Treatment Options in Cardiovascular Medicine",

issn = "1092-8464",

publisher = "Current Science, Inc.",

number = "5",

}

TY - JOUR

T1 - Saphenous vein graft interventions

AU - Brilakis, Emmanouil S.

AU - Lee, Michael

AU - Mehilli, Julinda

AU - Marmagkiolis, Konstantinos

AU - Rodes-Cabau, Josep

AU - Sachdeva, Rajesh

AU - Kotsia, Anna

AU - Christopoulos, George

AU - Rangan, Bavana V.

AU - Mohammed, Atif

AU - Banerjee, Subhash

PY - 2014/5

Y1 - 2014/5

N2 - Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.

AB - Saphenous vein graft (SVG) percutaneous coronary intervention (PCI) currently accounts for approximately 6% of all PCIs and is associated with increased risk for distal embolization and subsequent SVG failure compared with native coronary artery PCI. To minimize the risk for distal embolization, embolic protection devices should be used during SVG PCI when technically feasible. To minimize the risk for in-stent restenosis and the need for repeat PCI, drug eluting stents should be utilized in patients without contraindications to long-term antiplatelet therapy. Treating native coronary artery lesions is preferable to SVG PCI when technically feasible.

KW - Drug eluting stent

KW - Internal mammary artery

KW - Outcomes

KW - Percutaneous coronary intervention

KW - Saphenous vein grafts

UR - http://www.scopus.com/inward/record.url?scp=84898791888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898791888&partnerID=8YFLogxK

U2 - 10.1007/s11936-014-0301-x

DO - 10.1007/s11936-014-0301-x

M3 - Article

C2 - 24643432

AN - SCOPUS:84898791888

SN - 1092-8464

VL - 16

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

IS - 5

M1 - 301

ER -

Saphenous vein graft interventions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this